Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Directorate Change

16 Oct 2015 07:01

RNS Number : 4593C
ITE Group PLC
16 October 2015
 

 

16 October 2015

ITE Group plc

 

("ITE" or the "Group")

 

Directorate Change

 

ITE Group plc, the international exhibitions group specialising in emerging and developing markets, today announces that Neil Jones has informed the Board of his intention to resign from his position of Chief Financial Officer. Neil will be joining Huntsworth plc as Chief Financial Officer in February 2016.

 

Neil will remain at ITE Group plc until 31 January 2016 in order to close the current financial year end, and to ensure a smooth handover. The Board has commenced a search for his successor and a further announcement in relation to a new Chief Financial Officer will be made in due course as appropriate.

 

Marco Sodi, ITE's Chairman, said:

 

"On behalf of the Board and all of our employees, I would like to thank Neil for his contribution to the growth of the Group during his seven year tenure. His knowledge, drive and positive attitude have made him an excellent member of the executive management team and we wish him well for his future endeavours."

 

-ends-

Enquiries

Russell Taylor, CEO 020 7596 5000

Neil Jones, CFO

ITE Group plc

 

 

Charles Palmer 020 3727 1000

Emma Appleton

FTI Consulting

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUVSRRVKARAUA
Date   Source Headline
9th Mar 20222:09 pmRNSHolding(s) in Company
7th Mar 20224:27 pmRNSHolding(s) in Company
3rd Mar 20229:55 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSDirector/PDMR Shareholding
2nd Mar 202212:23 pmRNSDirector/PDMR Shareholding
1st Mar 20221:41 pmRNSHolding(s) in Company
28th Feb 20224:21 pmRNSHolding(s) in Company
28th Feb 20221:24 pmRNSResponse to the Russia/Ukraine conflict
28th Feb 202211:06 amRNSHolding(s) in Company
11th Feb 202212:50 pmRNSHolding(s) in Company
3rd Feb 20229:50 amRNSAnnouncement of Results of Annual General Meeting
3rd Feb 20227:00 amRNSBoard Changes
3rd Feb 20227:00 amRNSTrading Update
26th Jan 20222:50 pmRNSHolding(s) in Company
11th Jan 20229:33 amRNSHolding(s) in Company
5th Jan 202211:09 amRNSPublication of Annual Report and Notice of AGM
20th Dec 20213:17 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFY21 Preliminary Results
1st Dec 20217:00 amRNSVoting Rights and Capital
24th Nov 20215:17 pmRNSHolding(s) in Company
23rd Nov 20214:16 pmRNSHolding(s) in Company
23rd Nov 20211:59 pmRNSHolding(s) in Company
18th Nov 20211:54 pmRNSDirector/PDMR Shareholding
18th Nov 20219:41 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSProposed placing and direct subscription
11th Nov 20215:48 pmRNSCorrection - Director/PDMR Shareholding
26th Oct 20212:54 pmRNSDirector/PDMR Shareholding
25th Oct 202111:26 amRNSAnnouncement of Results of General Meeting
13th Oct 20211:16 pmRNSDirector Declaration
8th Oct 20219:28 amRNSNotice of General Meeting
7th Oct 20217:00 amRNSPre-close trading update
1st Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 20213:26 pmRNSHolding(s) in Company
20th Jul 20215:13 pmRNSHolding(s) in Company
13th Jul 20214:34 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSTrading Update
24th Jun 202110:38 amRNSHolding(s) in Company
23rd Jun 20219:13 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSResponse to recent press speculation
28th May 202111:48 amRNSHolding(s) in Company
26th May 202111:09 amRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
11th May 20212:16 pmRNSHolding(s) in Company
26th Apr 202112:44 pmRNSHolding(s) in Company
23rd Apr 20214:08 pmRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading Update
1st Apr 202110:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 202111:50 amRNSHolding(s) in Company
22nd Feb 20212:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.